NEVVI Medicare utilization intelligence
or

← back

Provider profile

MEENEGHAN, MATHEW M.D.

Hematology-Oncology · NPI 1467695460 · BASTROP, TX

1
Groups
82
Codes · 2024
137,383
Disclosed services

MEENEGHAN, MATHEW is a Hematology-Oncology in BASTROP, TX, a member of 1 medical group, who billed 82 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider analytics (2024)

MEENEGHAN, MATHEW billed 92,827 disclosed services in CY2023 and 137,383 in CY2024.

This provider's disclosed Medicare payments across all codes were $ in CY2024.

The full figure is part of the market analytics platform — built, not launched yet. Notify me at launch →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
J1756 Injection, iron sucrose, 1 mg
J9299 Injection, nivolumab, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J1453 Injection, fosaprepitant, 1 mg
J9267 Injection, paclitaxel, 1 mg
J0897 Injection, denosumab, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J9041 Injection, bortezomib, 0.1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
36415 Insertion of needle into vein for collection of blood sample
J1437 Injection, ferric derisomaltose, 10 mg
J0640 Injection, leucovorin calcium, per 50 mg
J9190 Injection, fluorouracil, 500 mg
J2469 Injection, palonosetron hcl, 25 mcg
82784 Gammaglobulin (immune system protein) measurement
J3480 Injection, potassium chloride, per 2 meq
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J1626 Injection, granisetron hydrochloride, 100 mcg
83521 Measurement of immunoglobulin light chains
96413 Administration of chemotherapy into vein, 1 hour or less
96375 Injection of additional new drug or substance into vein
83615 Lactate dehydrogenase (enzyme) level
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J7030 Infusion, normal saline solution , 1000 cc
83540 Iron level
83550 Iron binding capacity
82728 Ferritin (blood protein) level
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
J3475 Injection, magnesium sulfate, per 500 mg
J9045 Injection, carboplatin, 50 mg
J3489 Injection, zoledronic acid, 1 mg
96372 Injection of drug or substance under skin or into muscle
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
83735 Magnesium level
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
82378 Carcinoembryonic antigen (cea) protein level
85055 Reticulated (young) platelet measurement
96360 Infusion into a vein for hydration, 31-60 minutes
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
85007 Microscopic examination for white blood cells with manual cell count
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96415 Administration of chemotherapy into vein, each additional hour
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96417 Administration of additional new drug or substance into vein, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
82306 Vitamin d-3 level
96361 Infusion into a vein for hydration, each additional hour
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
84153 Psa (prostate specific antigen) measurement, total
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
J3490 Unclassified drugs
82607 Cyanocobalamin (vitamin b-12) level
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
82746 Folic acid level, serum
96374 Injection of drug or substance into vein
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
85045 Red blood count, automated test
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
96411 Administration of additional new drug or substance into vein using push technique
83010 Haptoglobin (serum protein) level
99195 Drawing of blood for a medical problem
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
84443 Blood test, thyroid stimulating hormone (tsh)
96377 Application of on-body injector for under skin injection
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
82270 Stool analysis for blood to screen for colon tumors

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.